In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bristol's Bid for Revival

Executive Summary

Without the revenue increases to fuel R&D budget growth, Bristol-Myers' new CSO James Palmer must make more of existing assets. As he describes it in this interview, his conservative approach is symbolic of an entire industry waking up to its over-reliance on internal discovery and unvalidated targets. And as part of his risk-lowering strategy, he will continue to move the company away from low-acuity primary-care markets to far more specialized, higher-acuity segments where safety is less of a concern with regulators than efficacy.
Advertisement

Related Content

Focusing R&D In The Age Of Speed: An Interview With Bristol-Myers Squibb CSO Francis Cuss
Generic Plavix: As Bristol Swoons, Broad Implications
Generic Plavix: As Bristol Swoons, Broad Implications
Corgentech/BMS: Finding Specialty Appeal in a Drug/Device Combo
Corgentech/BMS: Finding Specialty Appeal in a Drug/Device Combo
Blockbusters to New-Engine Drugs: The Key Industry Shift
Why Deal Accounting Matters
Pfizer R&D: The Biggest Pharmaceutical Experiment
Aventis's Global Management Challenge

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002197

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel